The US government and the Bill and Melinda Gates Foundation pledged Wednesday to jointly invest $200 million over the next four years to achieve affordable gene therapy-based cures for sickle cell disease (SCD) and HIV.
Continue reading “US and Gates Foundation plan $200m for sickle cell, HIV cures”
By Tobiloba Ishola
Lifting and Empowering All Families (L.E.A.F) Rwanda will start production of the first complex generic cancer medicine, L.E.A.F.-1404. This was announced after an agreement was reached with US Contract Manufacturing Organisation (CMO), through the firm’s parent company, LEAF Pharmaceuticals LLC, which is based in the United States. Continue reading “US-BASED PHARMACEUTICAL FIRM TO START MAKING CANCER DRUGS IN RWANDA”